Better DNA testing for unclear genetic results
Part of Cancer, Genetic & congenital clinical trials.
This study uses a new, advanced DNA sequencing method (long-read sequencing) to try to clarify unclear or incomplete genetic test results. If you or a family member have had genetic testing that left unanswered questions, this trial may help find more definite answers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or a family member must have had genetic testing that showed an unclear or incomplete result.
- Your previous testing found something like a copy number change of unknown significance, or only one change in a gene that usually needs two changes to cause disease.
- You are willing to provide a blood or saliva sample for advanced DNA sequencing that reads long pieces of your genome.
- You want to help researchers or doctors understand your genetic result better.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to use advanced genetic testing to better understand rare and genetic diseases. It may help find a diagnosis or guide personalized care for you or your child.
This study looks for a genetic (DNA) explanation for rare diseases when usual genetic testing hasn’t found an answer. It may help by re-analyzing prior results and comparing them with parents’ DNA to better pinpoint the cause.
This study uses advanced DNA sequencing to figure out unclear or unusual blood (hematologic) conditions when standard tests are not enough. It may help your care team reach a more accurate diagnosis by better understanding what’s driving your illness.
This trial uses a new DNA sequencing method that reads long stretches of DNA to find genetic causes of rare diseases. It is for people who have intellectual development disorders or albinism and have not yet gotten a clear genetic diagnosis from standard tests.
This study helps decide treatment planning based on genetic testing for people whose disease cause is unclear but may be genetic. It’s meant to support a “genomic health” approach, where results guide next steps in care.
This study aims to find genetic causes of epilepsy and use that information to personalize your care. It involves analyzing your DNA to look for gene changes that may be linked to your seizures.
Hear when a new Rare Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.